Accendra Health receives NYSE trading suspension notice over abnormally low share price
ACH•Accendra Health said the NYSE suspended trading in its common stock effective Nov. 16, 2026, and will begin delisting proceedings over abnormally low selling prices. The stock began trading on OTCQB under ACCH on Nov. 17.
1. Trading moves to OTCQB
Accendra Health received NYSE notification on Nov. 16, 2026, that trading in its NYSE-listed common stock would be suspended immediately and delisting proceedings would begin because of abnormally low selling prices. The stock began trading on OTCQB under ticker ACCH on Nov. 17. The company said the move does not affect its business operations or SEC reporting obligations and does not trigger defaults under material debt or other agreements.




